| Literature DB >> 2513416 |
S P Squinto1, A L Block, P Braquet, N G Bazan.
Abstract
Platelet-activating factor (PAF) elicits a rapid and transient activation of the proto-oncogenes c-fos and c-jun in SH-SY5Y neuroblastoma cells, but only to a minor extent in Molt-4 T-lymphocytes. This effect is inhibited by pretreatment of cells with the PAF antagonist BN 52021, suggesting the involvement of a specific receptor. Moreover, PAF treatment can activate gene expression through an AP-1 element, and we propose that genomic trans-activation may occur in target genes containing a functional AP-1 transcription sequence. These results may further understanding of the molecular mechanisms by which PAF contributes to long-term phenotypic changes in the nervous system.Entities:
Mesh:
Substances:
Year: 1989 PMID: 2513416 DOI: 10.1002/jnr.490240414
Source DB: PubMed Journal: J Neurosci Res ISSN: 0360-4012 Impact factor: 4.164